Competing risks of antiepileptic drug failure: Importance, measurement and analysis

被引:0
|
作者
Williamson, P.
Smith, C. Tudur
Sander, J.
Marson, A.
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] UCL, London, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [21] Vertical modelling: Analysis of competing risks data with missing causes of failure
    Nicolaie, M. A.
    van Houwelingen, H. C.
    Putter, H.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2015, 24 (06) : 891 - 908
  • [22] Importance of Comorbidity in Competing Risks Analysis in Patients With Localized Renal Cell Carcinoma
    Lagro, Joep
    Melis, Rene J.
    Rikkert, Marcel G. M. Olde
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18) : E298 - E298
  • [23] Survival analysis-part 3: intermediate events and the importance of competing risks
    Deo, Salil Vasudeo
    Deo, Vaishali
    Sundaram, Varun
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 37 (03) : 367 - 370
  • [24] Cumulative incidence in competing risks data and competing risks regression analysis
    Kim, Haesook T.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 559 - 565
  • [25] Failure of "rational" antiepileptic drug therapy
    Steinhoff, Bernhard J.
    Bacher, Matthias
    Fazekas, Inge
    Kurth, Christoph
    Wendling, Anne-Sophie
    Staack, Anke M.
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (02): : 160 - 164
  • [26] LIFE TESTS UNDER COMPETING CAUSES OF FAILURE AND THEORY OF COMPETING RISKS
    MOESCHBERGER, ML
    DAVID, HA
    BIOMETRICS, 1971, 27 (04) : 909 - +
  • [27] Comparison of failure probabilities in the presence of competing risks
    Bajorunaite, Ruta
    Klein, John P.
    JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION, 2008, 78 (10) : 951 - 966
  • [28] Competing risks data analysis under the accelerated failure time model with missing cause of failure
    Zheng, Ming
    Lin, Renxin
    Yu, Wen
    ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, 2016, 68 (04) : 855 - 876
  • [29] Competing risks data analysis under the accelerated failure time model with missing cause of failure
    Ming Zheng
    Renxin Lin
    Wen Yu
    Annals of the Institute of Statistical Mathematics, 2016, 68 : 855 - 876
  • [30] Computation of antiepileptic drug retention rates in the presence of a competing risk
    van der Meer, Pim B.
    Fiocco, Marta
    Koekkoek, Johan A. F.
    Taphoorn, Martin J. B.
    Dirven, Linda
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 67 : 82 - 82